• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化直接压片控释核心中盐酸曲美他嗪渗透泵片释放度的可行性。

Feasibility of optimizing trimetazidine dihydrochloride release from controlled porosity osmotic pump tablets of directly compressed cores.

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Egypt.

出版信息

J Adv Res. 2014 May;5(3):347-56. doi: 10.1016/j.jare.2013.05.005. Epub 2013 Jun 11.

DOI:10.1016/j.jare.2013.05.005
PMID:25685502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4294720/
Abstract

The aim of this study was to develop and optimize Trimetazidine dihydrochloride (TM) controlled porosity osmotic pump (CPOP) tablets of directly compressed cores. A 2(3) full factorial design was used to study the influence of three factors namely: PEG400 (10% and 25% based on coating polymer weight), coating level (10% and 20% of tablet core weight) and hole diameter (0 "no hole" and 1 mm). Other variables such as tablet cores, coating mixture of ethylcellulose (4%) and dibutylphthalate (2%) in 95% ethanol and pan coating conditions were kept constant. The responses studied (Yi ) were cumulative percentage released after 2 h (Q%2h), 6 h (Q%6h), 12 h (Q%12h) and regression coefficient of release data fitted to zero order equation (RSQzero), for Y 1, Y 2, Y 3, and Y 4, respectively. Polynomial equations were used to study the influence of different factors on each response individually. Response surface methodology and multiple response optimization were used to search for an optimized formula. Response variables for the optimized formula were restricted to 10% ⩽ Y 1 ⩽ 20%, 40% ⩽ Y 2 ⩽ 60%, 80% ⩽ Y 3 ⩽ 100%, and Y 4 > 0.9. The statistical analysis of the results revealed that PEG400 had positive effects on Q%2h, Q%6h and Q%12h, hole diameter had positive effects on all responses and coating level had positive effect on Q%6h, Q%12h and negative effect on RSQzero. Full three factor interaction (3FI) equations were used for representation of all responses except Q%2h which was represented by reduced (3FI) equation. Upon exploring the experimental space, no formula in the tested range could satisfy the required constraints. Thus, direct compression of TM cores was not suitable for formation of CPOP tablets. Preliminary trials of CPOP tablets with wet granulated cores were promising with an intact membrane for 12 h and high RSQzero. Further improvement of these formulations to optimize TM release will be done in further studies.

摘要

本研究旨在开发和优化曲美他嗪二盐酸盐(TM)控释渗透泵(CPOP)直接压片芯。采用 2(3)完全因子设计研究了三个因素的影响:聚乙二醇 400(基于包衣聚合物重量的 10%和 25%)、包衣水平(片剂芯重量的 10%和 20%)和孔径(0“无孔”和 1 毫米)。其他变量,如片剂芯、乙基纤维素(4%)和邻苯二甲酸二丁酯(2%)在 95%乙醇中的包衣混合物和锅包衣条件保持不变。研究的响应(Yi)分别为 2 小时(Q%2h)、6 小时(Q%6h)、12 小时(Q%12h)后的累积释放百分比和拟合零级方程(RSQzero)的释放数据的回归系数(Y1、Y2、Y3 和 Y4)。使用多项式方程研究不同因素对每个响应的单独影响。响应面法和多响应优化用于搜索优化配方。优化配方的响应变量限于 10%≤Y1≤20%、40%≤Y2≤60%、80%≤Y3≤100%和 Y4>0.9。结果的统计分析表明,PEG400 对 Q%2h、Q%6h 和 Q%12h 有积极影响,孔径对所有响应有积极影响,包衣水平对 Q%6h、Q%12h 有积极影响,对 RSQzero 有消极影响。除 Q%2h 外,所有响应均采用完整三因子相互作用(3FI)方程表示,Q%2h 采用简化(3FI)方程表示。在探索实验空间时,在所测试范围内,没有配方能够满足所需的约束。因此,TM 芯的直接压缩不适合形成 CPOP 片剂。用湿法制粒芯制成的 CPOP 片剂的初步试验很有希望,能保持完整的膜 12 小时,RSQzero 高。在进一步的研究中,将对这些制剂进行进一步改进,以优化 TM 的释放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/24d2e2c16778/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/29f134c1fab2/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/884679bd3a9c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/cbb9a469fa58/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/8b55b3d897f9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/24d2e2c16778/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/29f134c1fab2/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/884679bd3a9c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/cbb9a469fa58/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/8b55b3d897f9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/4294720/24d2e2c16778/gr4.jpg

相似文献

1
Feasibility of optimizing trimetazidine dihydrochloride release from controlled porosity osmotic pump tablets of directly compressed cores.优化直接压片控释核心中盐酸曲美他嗪渗透泵片释放度的可行性。
J Adv Res. 2014 May;5(3):347-56. doi: 10.1016/j.jare.2013.05.005. Epub 2013 Jun 11.
2
The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.成孔剂和增塑剂对盐酸地尔硫䓬从控孔渗透泵中释放动力学的影响。
Drug Res (Stuttg). 2013 Aug;63(8):414-9. doi: 10.1055/s-0033-1343429. Epub 2013 Apr 18.
3
Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.盐酸曲马多每日一次控释微孔渗透泵的研制与评价
AAPS PharmSciTech. 2016 Oct;17(5):1248-60. doi: 10.1208/s12249-015-0463-1. Epub 2015 Dec 17.
4
Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.控释给药系统中的微孔表面:使用非离子表面活性剂作为致孔剂设计和评价盐酸地尔硫卓控释渗透泵。
Pharm Dev Technol. 2014 Jun;19(4):507-12. doi: 10.3109/10837450.2013.805774. Epub 2013 Jun 13.
5
Production and evaluation of a lamotrigine extended release tablet based on a controlled-porosity osmotic pump system.基于控孔渗透泵系统的拉莫三嗪缓释片的制备与评价
Pharmazie. 2017 Sep 1;72(9):511-517. doi: 10.1691/ph.2017.7054.
6
Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems.微悬浮包衣法:控孔渗透泵系统制剂研发的新方法。
Drug Res (Stuttg). 2014 Apr;64(4):203-7. doi: 10.1055/s-0033-1355336. Epub 2013 Sep 11.
7
Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.依托度酸控释渗透泵片的研制及体外/体内评价。
AAPS PharmSciTech. 2011 Jun;12(2):485-95. doi: 10.1208/s12249-011-9608-z. Epub 2011 Apr 9.
8
Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.基于质量源于设计(QbD)的数值和图形优化技术,开发渗透泵控释盐酸甲氧氯普胺片。
Drug Des Devel Ther. 2020 Nov 26;14:5217-5234. doi: 10.2147/DDDT.S278918. eCollection 2020.
9
Nano-suspension coating as a technique to modulate the drug release from controlled porosity osmotic pumps for a soluble agent.
Colloids Surf B Biointerfaces. 2017 May 1;153:27-33. doi: 10.1016/j.colsurfb.2017.02.007. Epub 2017 Feb 8.
10
Trimetazidine Dihydrochloride Pulsatile-Release Tablets for the Treatment of Morning Anginal Symptoms: Dual Optimization, Characterization and Pharmacokinetic Evaluation.盐酸曲美他嗪脉冲释放片治疗晨发性心绞痛症状:双重优化、特征描述和药代动力学评价。
Curr Drug Deliv. 2021;18(8):1182-1196. doi: 10.2174/1567201818666210212095932.

引用本文的文献

1
SeDeM tool-driven full factorial design for osmotic drug delivery of tramadol HCl: Formulation development, physicochemical evaluation, and PBPK modeling for predictive pharmacokinetic evaluation using GastroPlus™.用于盐酸曲马多渗透给药的SeDeM工具驱动全因子设计:制剂开发、理化评价以及使用GastroPlus™进行预测性药代动力学评价的PBPK建模
Front Pharmacol. 2022 Oct 7;13:974715. doi: 10.3389/fphar.2022.974715. eCollection 2022.
2
D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against .D-最优混合设计优化局部氨苯砜非离子囊泡:体外特性和体内对.的活性
Drug Deliv. 2022 Dec;29(1):821-836. doi: 10.1080/10717544.2022.2048131.
3

本文引用的文献

1
The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy.曲美他嗪对特发性扩张型心肌病糖尿病患者心功能的影响。
Life Sci. 2013 Mar 28;92(11):633-8. doi: 10.1016/j.lfs.2012.03.015. Epub 2012 Mar 28.
2
Dynamic and static curing of ethylcellulose:PVA-PEG graft copolymer film coatings.乙基纤维素:PVA-PEG 接枝共聚物膜涂层的动态和静态固化。
Eur J Pharm Biopharm. 2011 Aug;78(3):455-61. doi: 10.1016/j.ejpb.2011.02.010. Epub 2011 Feb 22.
3
Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system.
Double-layered osmotic pump controlled release tablets of actarit: and evaluation.
阿扎司琼双层渗透泵控释片及其评价
Asian J Pharm Sci. 2019 May;14(3):340-348. doi: 10.1016/j.ajps.2018.05.009. Epub 2018 Aug 19.
采用夹芯渗透泵片系统同时递送硝苯地平和酒石酸美托洛尔。
Int J Pharm. 2010 Oct 31;399(1-2):60-70. doi: 10.1016/j.ijpharm.2010.08.003. Epub 2010 Aug 7.
4
Floating tablet of trimetazidine dihydrochloride: an approach for extended release with zero-order kinetics.盐酸曲美他嗪漂浮片:一种具有零级动力学的延长释放方法。
AAPS PharmSciTech. 2010 Sep;11(3):1058-67. doi: 10.1208/s12249-010-9468-y. Epub 2010 Jun 26.
5
Curing of aqueous polymeric film coatings: Importance of the coating level and type of plasticizer.水性聚合物膜包衣的固化:包衣水平和增塑剂类型的重要性。
Eur J Pharm Biopharm. 2010 Feb;74(2):362-70. doi: 10.1016/j.ejpb.2009.10.007. Epub 2009 Nov 4.
6
A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation.一种新型胃驻留渗透泵片:体外与体内评价。
Int J Pharm. 2010 Jan 4;383(1-2):30-6. doi: 10.1016/j.ijpharm.2009.08.043. Epub 2009 Sep 4.
7
Oral osmotically driven systems: 30 years of development and clinical use.口服渗透压驱动系统:30 年的发展与临床应用。
Eur J Pharm Biopharm. 2009 Nov;73(3):311-23. doi: 10.1016/j.ejpb.2009.07.002. Epub 2009 Jul 12.
8
Approach to design push-pull osmotic pumps.推挽式渗透泵的设计方法。
Int J Pharm. 2009 Jul 6;376(1-2):56-62. doi: 10.1016/j.ijpharm.2009.04.015. Epub 2009 Apr 19.
9
Extrudable core system: development of a single-layer osmotic controlled-release tablet.可挤出核心系统:单层渗透控释片的研发
J Control Release. 2009 Mar 19;134(3):201-6. doi: 10.1016/j.jconrel.2008.11.017. Epub 2008 Dec 3.
10
Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.通过包衣压痕片芯制备双层核心渗透泵片。
Int J Pharm. 2008 Mar 20;352(1-2):225-30. doi: 10.1016/j.ijpharm.2007.10.047. Epub 2007 Nov 6.